SUBSCRIBERS

Stocks to watch: SGX, Cordlife, Digital Core Reit

Crystal Heng
Published Mon, Sep 9, 2024 · 08:19 AM
    • Cordlife has accepted a notice from the Ministry of Health regarding changes to its cord-blood banking service licence.
    • Cordlife has accepted a notice from the Ministry of Health regarding changes to its cord-blood banking service licence. PHOTO: BT FILE

    THE following companies saw new developments that may affect trading of their securities on Monday (Sep 9):

    Singapore Exchange (SGX): The bourse’s total securities market turnover in August rose 22 per cent on the year to S$28.8 billion, while securities daily average value climbed 28 per cent on the year to S$1.4 billion. This comes as retail investors’ net purchases hit a new high of S$685 million, adding positions in index stocks as well as small and mid-caps. Shares of SGX closed 0.7 per cent or S$0.08 lower at S$10.87 on Friday.

    Cordlife : The embattled cord-blood bank on Friday said it has accepted a notice from the Ministry of Health regarding changes to its cord-blood banking service licence, in a bid to resume its cord-blood banking service. It will not collect, test, process and/or store more than 30 units per month of new cord blood from infant donors from Sep 15 to Jan 13, 2025, unless approved sooner by the director-general of health. The counter closed 3.7 per cent or S$0.005 higher at S$0.14, before the announcement.

    Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.

    Copyright SPH Media. All rights reserved.